Hemosense Performance

Hemosense Relative Risk vs. Return Landscape

If you would invest (100.00) in Hemosense on September 26, 2024 and sell it today you would earn a total of  100.00  from holding Hemosense or generate -100.0% return on investment over 90 days. Hemosense is generating negative expected returns assuming volatility of 0.0% on return distribution over 90 days investment horizon. In other words, 0% of stocks are less volatile than Hemosense, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  

Hemosense Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Hemosense's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Hemosense, and traders can use it to determine the average amount a Hemosense's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
HEM
Based on monthly moving average Hemosense is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hemosense by adding Hemosense to a well-diversified portfolio.

Things to note about Hemosense performance evaluation

Checking the ongoing alerts about Hemosense for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Hemosense help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Hemosense is not yet fully synchronised with the market data
Hemosense has some characteristics of a very speculative penny stock
Evaluating Hemosense's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Hemosense's stock performance include:
  • Analyzing Hemosense's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Hemosense's stock is overvalued or undervalued compared to its peers.
  • Examining Hemosense's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Hemosense's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Hemosense's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Hemosense's stock. These opinions can provide insight into Hemosense's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Hemosense's stock performance is not an exact science, and many factors can impact Hemosense's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Consideration for investing in Hemosense Stock

If you are still planning to invest in Hemosense check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hemosense's history and understand the potential risks before investing.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals